MedTrace Logo

Regional Registry-based Biobank Development and Pharmacogenetic Analysis in Rheumatoid Arthritis

NCT03555240 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2019-11-12

No results posted yet for this study

Summary

Aim of this project is the building-up of an integrated model of multidisciplinary research tools to support large-scale and high-quality disease-based studies.

Conditions

Interventions

OTHER

Biobank creation and Pharmacogenetic analysis

Collection of biological samples (blood, serum, plasma) form patient enrolled in the Emilia Romagna rheumatoid arthritis registry and genotyping genomic DNA samples, and assessing the association between genotypes and response to biological drugs, using multivariate and data-mining approaches that includes also clinical and demographic parameters.

Sponsors & Collaborators

  • Regione Emilia Romagna - Italy within PRU-Liberati project

    collaborator UNKNOWN

  • Istituto Ortopedico Rizzoli

    lead OTHER

Principal Investigators

  • Elisa Assirelli, BSc · Rizzoli Orthopedic Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-27
Primary Completion
2018-09-28
Completion
2018-09-28

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03555240 on ClinicalTrials.gov